{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:16:48Z","timestamp":1785406608130,"version":"3.56.0"},"reference-count":61,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Medical University of Bia\u0142ystok","doi-asserted-by":"publisher","award":["B.SUB.26.171"],"award-info":[{"award-number":["B.SUB.26.171"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"award":["B.SUB.26.171"],"award-info":[{"award-number":["B.SUB.26.171"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Prostate cancer (PCa) is the most common malignancy in men. Recent evidence indicates a correlation between modulation of the tumor microenvironment, tumor growth and metastasis. Chemokines, including C-C chemokine ligand 2 (CCL2) and C-C chemokine ligand 7 (CCL7), participate in regulating inflammation, angiogenesis, and the recruitment of immunosuppressive cells. This study aimed to assess the diagnostic potential of serum CCL2 and CCL7 in patients with PCa, benign prostatic hyperplasia (BPH) and healthy controls. The study included 53 patients with PCa, divided into groups at low, intermediate, and high risk of disease progression, 55 with BPH, and 30 healthy controls. CCL2 and CCL7 concentrations were measured using a multiplex Luminex assay. Serum CCL7 concentration in PCa patients was significantly lower compared to controls. No significant differences in its concentration were found between PCa and BPH patients or between PCa subgroups at different risk levels. CCL7 demonstrated promising sensitivity (96.2%) and AUC (0.917). However, its ability to distinguish PCa from BPH was limited. CCL2 concentrations were significantly lower in the PCa group only compared to the BPH group. These results suggest that CCL7 may represent a potential adjunct marker within multimarker diagnostic strategies for prostate cancer, while CCL2 showed limited diagnostic utility.<\/jats:p>","DOI":"10.3390\/ijms27146197","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:53:58Z","timestamp":1783932838000},"page":"6197","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum CCL2 and CCL7 in Prostate Cancer: Evaluation of Their Diagnostic Utility in Comparison with Benign Prostatic Hyperplasia and Healthy Controls"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2650-0996","authenticated-orcid":false,"given":"Weronika","family":"Sok\u00f3lska","sequence":"first","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5179-0722","authenticated-orcid":false,"given":"Monika","family":"Zajkowska","sequence":"additional","affiliation":[{"name":"Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Rafa\u0142","family":"Nowi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Urology, Independent Public Health Care Center of the Ministry of the Interior and Administration in Bia\u0142ystok, Fabryczna 27, 15-471 Bia\u0142ystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-8098","authenticated-orcid":false,"given":"Karolina","family":"Orywal","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A, 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Majewska, Z., Zajkowska, M., P\u0105czek, S., Nowi\u0144ski, A.R., Sok\u00f3lska, W., Gryko, M., and Orywal, K. (2025). The Clinical Relevance of Tumor Biomarkers in Prostate Cancer\u2014A Review. Cancers, 17.","DOI":"10.3390\/cancers17233742"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., and Mashele, S. (2022). Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. Molecules, 27.","DOI":"10.3390\/molecules27175730"},{"key":"ref_3","first-page":"485","article-title":"Prostate Cancer Statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Wu, L., Qiu, J., Hong, Z., Wang, Q., Li, Q., and Zhou, W. (2025). Unravelling Targeted Therapy in Prostate Cancer: From Molecular Mechanisms to Translational Opportunities. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1685857"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104738","DOI":"10.1016\/j.ebiom.2023.104738","article-title":"BRCA-Deficient Metastatic Prostate Cancer Has an Adverse Prognosis and Distinct Genomic Phenotype","volume":"95","author":"Fettke","year":"2023","journal-title":"eBioMedicine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41589-022-01151-y","article-title":"Targeting Androgen Receptor Phase Separation to Overcome Antiandrogen Resistance","volume":"18","author":"Xie","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-022-30257-z","article-title":"MYC Drives Aggressive Prostate Cancer by Disrupting Transcriptional Pause Release at Androgen Receptor Targets","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s10020-022-00504-6","article-title":"The Novel Transcriptomic Signature of Angiogenesis Predicts Clinical Outcome, Tumor Microenvironment and Treatment Response for Prostate Adenocarcinoma","volume":"28","author":"Gu","year":"2022","journal-title":"Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Wu, W., Wang, X., Le, W., Lu, C., Li, H., Zhu, Y., Chen, X., An, W., Xu, C., and Wu, Q. (2023). Immune Microenvironment Infiltration Landscape and Immune-Related Subtypes in Prostate Cancer. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1001297"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"216814","DOI":"10.1016\/j.canlet.2024.216814","article-title":"Candida albicans-Myeloid Cells-T Lymphocytes Axis in the Tumor Microenvironment of Oral Tumor-Bearing Mice","volume":"588","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"216807","DOI":"10.1016\/j.canlet.2024.216807","article-title":"LRP1 Induces Anti-PD-1 Resistance by Modulating the DLL4-NOTCH2-CCL2 Axis and Redirecting M2-Like Macrophage Polarisation in Bladder Cancer","volume":"593","author":"Lin","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Takacs, G.P., Kreiger, C.J., Luo, D., Tian, G., Garcia, J.S., Deleyrolle, L.P., Mitchell, D.A., and Harrison, J.K. (2023). Glioma-Derived CCL2 and CCL7 Mediate Migration of Immune Suppressive CCR2+\/CX3CR1+ M-MDSCs into the Tumor Microenvironment in a Redundant Manner. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.993444"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40164-024-00550-2","article-title":"M2-Like Tumor-Associated Macrophage-Secreted CCL2 Facilitates Gallbladder Cancer Stemness and Metastasis","volume":"13","author":"Chen","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","article-title":"Tumor-Associated Macrophages Promote Epithelial\u2013Mesenchymal Transition and the Cancer Stem Cell Properties in Triple-Negative Breast Cancer through CCL2\/AKT\/\u03b2-Catenin Signaling","volume":"20","author":"Chen","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yi, X., Li, J., Li, Y., Huang, T., Xiong, B., Zhang, F., and Zhao, Z. (2024). Predictive Diagnostic Value of Mean Platelet Volume to Platelet Count and Neutrophil to Lymphocyte Ratios in the Gray Zone of Prostate Cancer with tPSA between 4 to 10 ng\/mL. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1454124"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"H\u00f6ti, N., Lih, T.S., Dong, M., Zhang, Z., Mangold, L., Partin, A.W., Sokoll, L.J., Li, Q.K., and Zhang, H. (2023). Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection. Cancers, 15.","DOI":"10.3390\/cancers15030960"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.21037\/tau-23-80","article-title":"Comparisons of the Diagnostic Accuracy across Prostate Health Index, Prostate Health Index Density, and Percentage Free Prostate-Specific Antigen for Clinically Significant Prostate Cancer: A Prospective Diagnostic Study","volume":"12","author":"Wu","year":"2023","journal-title":"Transl. Androl. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eururo.2016.03.015","article-title":"Impact of Prostate-Specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications","volume":"71","author":"Gershman","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a Polygenic Risk Score in Screening for Prostate Cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation with or without Androgen Deprivation Therapy for Localized Prostate Cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xie, M., Gao, X.S., Ma, M.W., Gu, X.B., Li, H.Z., Lyu, F., Bai, Y., Chen, J.Y., Ren, X.Y., and Liu, M.Z. (2021). Population-Based Comparison of Different Risk Stratification Systems among Prostate Cancer Patients. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.646073"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, L., Jiang, K., Li, D., Li, D., Fan, Z., Dai, G., Tu, S., Liu, X., and Wei, G. (2021). The Chemokine CXCL7 Is Related to Angiogenesis and Associated with Poor Prognosis in Colorectal Cancer Patients. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.754221"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00262-024-03650-4","article-title":"Chemokine CCL21 Determines Immunotherapy Response in Hepatocellular Carcinoma by Affecting Neutrophil Polarization","volume":"73","author":"Xu","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/intimm\/dxad003","article-title":"PCBP1 Acts as a Regulator of CCL2 Expression in Macrophages to Induce Recruitment of Monocyte-Derived Macrophages into the Inflamed Colon","volume":"35","author":"Yang","year":"2023","journal-title":"Int. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"218410","DOI":"10.1016\/j.canlet.2026.218410","article-title":"FAP+ Fibroblasts Promote C1QC+ Macrophage Infiltration via WNT2 Signaling to Exacerbate T Cell Exhaustion in Oral Squamous Cell Carcinoma","volume":"646","author":"Chen","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2009.06.081","article-title":"Inflammatory Cytokines Stimulate the Chemokines CCL2\/MCP-1 and CCL7\/MCP-3 through NF\u03baB- and MAPK-Dependent Pathways in Rat Astrocytes","volume":"1287","author":"Thompson","year":"2009","journal-title":"Brain Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"101671","DOI":"10.1016\/j.mcp.2020.101671","article-title":"The CCL2\/CCL7\/CCL12\/CCR2 Pathway Is Substantially and Persistently Upregulated in Mice after Traumatic Brain Injury, and CCL2 Modulates the Complement System in Microglia","volume":"54","author":"Ciechanowska","year":"2020","journal-title":"Mol. Cell. Probes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13601-020-00367-2","article-title":"Chemokines during Anaphylaxis: The Importance of CCL2 and CCL2-Dependent Chemotactic Activity for Basophils","volume":"10","author":"Vantur","year":"2020","journal-title":"Clin. Transl. Allergy"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41421-022-00403-4","article-title":"Molecular Insights into Ligand Recognition and Activation of Chemokine Receptors CCR2 and CCR3","volume":"8","author":"Shao","year":"2022","journal-title":"Cell Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s42003-020-01441-y","article-title":"Inhibition of the CCL2 Receptor, CCR2, Enhances Tumor Response to Immune Checkpoint Therapy","volume":"3","author":"Tu","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12964-024-01746-z","article-title":"Targeting CCL2\u2013CCR2 Signaling Pathway Alleviates Macrophage Dysfunction in COPD via PI3K-AKT Axis","volume":"22","author":"Dong","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bcp.2011.11.013","article-title":"CCL2 Increases MMP-9 Expression and Cell Motility in Human Chondrosarcoma Cells via the Ras\/Raf\/MEK\/ERK\/NF-\u03baB Signaling Pathway","volume":"83","author":"Tang","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17448069231169373","DOI":"10.1177\/17448069231169373","article-title":"Chemokine CCL7 Mediates Trigeminal Neuropathic Pain via CCR2\/CCR3-ERK Pathway in the Trigeminal Ganglion of Mice","volume":"19","author":"Zhu","year":"2023","journal-title":"Mol. Pain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1016\/j.bbagen.2013.06.033","article-title":"CCL2 Increases \u03b1v\u03b23 Integrin Expression and Subsequently Promotes Prostate Cancer Migration","volume":"1830","author":"Lin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_35","first-page":"445","article-title":"Tumor-Associated Macrophages and PD-L1 in Prostate Cancer: A Possible Key to Unlocking Immunotherapy Efficacy","volume":"16","author":"Wang","year":"2024","journal-title":"Aging"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pan, Y., Song, Q., Lai, B., and Ma, H. (2026). Advances in the Identification of Novel Cell Signatures in Benign Prostatic Hyperplasia and Prostate Cancer Using Single-Cell RNA Sequencing. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1684895"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"eabo4314","DOI":"10.1126\/scisignal.abo4314","article-title":"The Dual-Function Chemokine Receptor CCR2 Drives Migration and Chemokine Scavenging through Distinct Mechanisms","volume":"16","author":"Shroka","year":"2023","journal-title":"Sci. Signal."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Marsland, M., Jiang, C.C., Faulkner, S., Steigler, A., McEwan, K., Jobling, P., Oldmeadow, C., Delahunt, B., Denham, J.W., and Hondermarck, H. (2024). CCL2\/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial. Cancers, 16.","DOI":"10.3390\/cancers16162794"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Iwamoto, H., Izumi, K., Nakagawa, R., Toriumi, R., Aoyama, S., Kamijima, T., Shimada, T., Kano, H., Makino, T., and Naito, R. (2022). Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer. Biomedicines, 10.","DOI":"10.3390\/biomedicines10102369"},{"key":"ref_40","first-page":"1337","article-title":"Usefulness of Serum CCL2 as Prognostic Biomarker in Prostate Cancer: A Long-Term Follow-Up Study","volume":"52","author":"Iwamoto","year":"2022","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Li, W., Chen, F., Gao, H., Xu, Z., Zhou, Y., Wang, S., Lv, Z., Zhang, Y., Xu, Z., and Huo, J. (2023). Cytokine Concentration in Peripheral Blood of Patients with Colorectal Cancer. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1175513"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kishimoto, T., Fujimoto, N., Ebara, T., Omori, T., Oguri, T., Niimi, A., Yokoyama, T., Kato, M., Usami, I., and Nishio, M. (2019). Serum Levels of the Chemokine CCL2 Are Elevated in Malignant Pleural Mesothelioma Patients. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6419-1"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Korbecki, J., Kojder, K., Simi\u0144ska, D., Bohatyrewicz, R., Gutowska, I., Chlubek, D., and Baranowska-Bosiacka, I. (2020). CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218412"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4143\/crt.2014.015","article-title":"CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study","volume":"47","author":"Tsaur","year":"2015","journal-title":"Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1038\/ncomms10230","article-title":"Periprostatic Adipocytes Act as a Driving Force for Prostate Cancer Progression in Obesity","volume":"7","author":"Laurent","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/cncr.35012","article-title":"Racial Differences in Serum Chemokines in Prostate Cancer Patients","volume":"129","author":"Karan","year":"2023","journal-title":"Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21873\/anticanres.16139","article-title":"Serum CCL7 Is a Novel Prognostic Biomarker of Metastatic Colorectal Cancer","volume":"43","author":"Chidimatsu","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12957-026-04265-y","article-title":"CCL Chemokines as Prognostic and Immunotherapeutic Markers in Prostate Cancer: A Comprehensive Analysis","volume":"24","author":"Bai","year":"2026","journal-title":"World J. Surg. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Sok\u00f3lska, W., Zajkowska, M., Kulczy\u0144ska-Przybik, A., Werel, T., and Orywal, K. (2026). Serum Chemokines CCL3 and CCL7 as Complementary Diagnostic Biomarkers across Tumor Grades in Clear Cell Renal Cell Carcinoma. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27052490"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/or.2012.1815","article-title":"CC Chemokine Ligand 7 Expression in Liver Metastasis of Colorectal Cancer","volume":"28","author":"Cho","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s41590-024-02032-3","article-title":"IL-4 Promotes Immunotherapy Resistance","volume":"25","author":"Jauregui","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_52","first-page":"442","article-title":"High CCL7 Expression Is Associated with Migration, Invasion and Bone Metastasis of Non-Small Cell Lung Cancer Cells","volume":"11","author":"Han","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.2337\/db07-0425","article-title":"Absence of CC Chemokine Ligand 2 Does Not Limit Obesity-Associated Infiltration of Macrophages into Adipose Tissue","volume":"56","author":"Inouye","year":"2007","journal-title":"Diabetes"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chan, P.C., Lu, C.H., Chien, H.C., Tian, Y.F., and Hsieh, P.S. (2022). Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation via CCR5 Receptor in High-Fat Diet-Fed Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214226"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Pan, X., Kaminga, A.C., Wen, S.W., and Liu, A. (2021). Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.622438"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12933-022-01626-1","article-title":"CCL7 as a Novel Inflammatory Mediator in Cardiovascular Disease, Diabetes Mellitus, and Kidney Disease","volume":"21","author":"Chang","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5902947","DOI":"10.1155\/2016\/5902947","article-title":"Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems","volume":"2016","author":"Dusi","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1042\/CS20257214","article-title":"Chemokine Receptors in Vascular Biology: A Review of Current Evidence, Implications, and Therapeutic Targets for Hypertension","volume":"139","author":"Beling","year":"2025","journal-title":"Clin. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1476-5381.2009.00612.x","article-title":"Statins Suppress Interleukin-6-Induced Monocyte Chemoattractant Protein-1 by Inhibiting Janus Kinase\/Signal Transducers and Activators of Transcription Pathways in Human Vascular Endothelial Cells","volume":"159","author":"Jougasaki","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.dsx.2020.08.016","article-title":"Effect of Metformin and Insulin Combination on Monocyte Chemoattractant Protein-1 and Cathepsin-D in Type 2 Diabetes Mellitus","volume":"14","author":"Kher","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"19943","DOI":"10.1038\/s41598-021-99412-8","article-title":"Irbesartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Colitis-Associated Tumourigenesis by Blocking the MCP-1\/CCR2 Pathway","volume":"11","author":"Hachiya","year":"2021","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6197\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:55:42Z","timestamp":1783932942000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":61,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146197"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146197","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}